首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1084876

细胞毒药物合同製造市场规模/份额/前景/机会（2022-2028）：生产规模/形式/产品类型/地区

Cytotoxic Drugs Contract Manufacturing Market, by Production Scale, by Form, by Product Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月29日 | 出版商:

Coherent Market Insights | 英文 193 Pages | 商品交期: 2-3个工作天内

价格

简介目录

细胞毒性药物的合同製造市场在过去十年中显着增长。癌症发病率增加、大公司业务扩张以及联盟和收购等各种增长战略的增加等因素预计将在预测期内推动市场增长。製药公司越来越多地采用合同製造服务也有望在预测期内推动市场增长。

本报告调查了全球细胞毒药物合同製造市场，定义和概述了市场，分析了对市场增长、法律和监管环境、技术趋势、市场规模变化和预测的各种影响因素，总结了细分市场各品类/地区/主要国家、竞争环境、主要公司概况等。

热图分析
市场份额分析
- Lonza Group
- Piramal Group
- Evonik Industries AG
- Novasep Holding SAS
- Merck KGaA(SAFC Pharma)
- Baxter Biopharma Solutions
- AbbVie Contract Manufacturing
- Cambrex Corporation
- CordenPharma International
- BSP Pharmaceuticals SpA
- Catalent, Inc.
- Albany Molecular Research Inc.(AMRI)
- Evotec
- WuXi AppTec Co., Ltd.
- Pierre Fabre Laboratories
- Dishman Group
分析师见解

第9章章节

简介目录

Product Code: CMI3175

Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.

Market Dynamics

Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.

Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2021, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology's COPIKTRA (duvelisib) capsules.

Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2021, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients (APIs) for its Parkinson's disease therapies.

Key features of the study:

This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market

Detailed Segmentation:

Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale:
- Industrial scale
- Pilot Scale
- Laboratory Scale
Global Cytotoxic Drugs Contract Manufacturing Market, By Form:
- Liquid
- Solid
Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type:
- Oral
- Intravenous
Global Cytotoxic Drugs Contract Manufacturing Market, By Region:
- North America
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Lonza Group*
  - Company Overview
  - Material Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Piramal Group
- Evonik Industries AG
- Novasep Holding SAS
- Merck KGaA (SAFC Pharma)
- Baxter Biopharma Solutions
- AbbVie Contract Manufacturing
- Cambrex Corporation
- BSP Pharmaceuticals S.p.A.
- CordenPharma International
- Catalent, Inc.
- Albany Molecular Research Inc. (AMRI)
- Evotec
- WuXi AppTec Co., Ltd.
- Pierre Fabre Laboratories
- Dishman Group

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Production Scale
- Market Snippet, By Form
- Market Snippet, By Product Type
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Epidemiology
Market Trends
Product Launch
Regulatory Scenario
PEST Analysis
Merger and Acquisition Scenario
Technological Advancements

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028(%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Industrial scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Pilot Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Laboratory Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028(%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Liquid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Solid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028(%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Lonza Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Piramal Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Evonik Industries AG
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novasep Holding SAS
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck KGaA (SAFC Pharma)
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter Biopharma Solutions
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Contract Manufacturing
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cambrex Corporation
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CordenPharma International
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BSP Pharmaceuticals S.p.A.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Catalent, Inc.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Albany Molecular Research Inc. (AMRI)
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Evotec
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- WuXi AppTec Co., Ltd.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pierre Fabre Laboratories
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dishman Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Analyst Views

9. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

细胞毒药物合同製造市场规模/份额/前景/机会（2022-2028）：生产规模/形式/产品类型/地区

Cytotoxic Drugs Contract Manufacturing Market, by Production Scale, by Form, by Product Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目录

第 1 章调查目标/先决条件

第二章市场概述

第三章市场动态/法律法规/趋势分析

第 4 章全球细胞毒性药物合同製造市场：按生产规模

第 5 章全球细胞毒性药物合同製造市场：按形式

第 6 章全球细胞毒性药物合同製造市场：按产品类型

第 7 章全球细胞毒性药物合同製造市场：按地区

第8章竞争态势